This is the authors' abstract. We don't add key points for this paper.
Telomere 3' overhang-specific DNA oligonucleotides (T-oligos) induce cancer cell death, presumably by mimicking telomere loop disruption and are, therefore, considered a promising new therapeutic strategy. We previously demonstrated that T-oligos inhibit the proliferation of malignant glioma cells in vitro and in vivo by inducing non-apoptotic autophagy. Using a reverse-phase protein microarray analysis and Western blotting, we revealed that T-oligos inhibit the mammalian target of rapamycin (mTOR) and the signal transducer and activator of transcription 3 (STAT3). Moreover, rapamycin (mTOR inhibitor) and AG490 (STAT3 inhibitor) sensitize malignant glioma cells to T-oligos by augmenting autophagy. Although mTOR is well known as a negative regulator of autophagy, the relationship between STAT3 and autophagy has never been demonstrated, to our knowledge. These findings suggest that, by exhibiting a novel mechanism of inducing autophagy through inhibition of mTOR and STAT3, T-oligos are a promising therapeutic agent for treating malignant gliomas. Here, we discuss evidence for T-oligos’ effects on cell signaling pathways that may explain their ability to stimulate autophagy by inhibiting STAT3 as well as mTOR.Addendum to:Telomere 3' Overhang-Specific DNA Oligonucleotides Induce Autophagy in Malignant Glioma CellsH. Aoki, E. Iwado, M.S. Eller, Y. Kondo, K. Fujiwara, G.-Z. Li, K.R. Hess, D.R. Siwak, R. Sawaya, G.B. Mills, B.A. Gilchrest and S. KondoFASEB J 2007; Epub ahead of print
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yokoyama et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: